Inactive Instrument

Other languages Freeline Therapeutics Holdings plc

Equities

Syncona’s Takeover of Freeline Therapeutics Becomes Effective	Feb. 20
Freeline Therapeutics Holdings plc Announces Resignation of Julia Gregory, Martin Andrews, Jeffrey Chodakewitz, Colin Love and Paul Schneider from the Board	Feb. 20
Syncona Investment Management Limited completed the acquisition of the remaining 42.08% stake in Freeline Therapeutics Holdings plc.	Feb. 19
Freeline shareholders approve Syncona acquisition	Feb. 12
Freeline Therapeutics' Shareholders Approve Acquisition by Syncona	Feb. 12
Syncona says Freeline trial for Gaucher disease treatment positive	Jan. 19
European Equities Traded in the US as American Depositary Receipts Gain Friday	Dec. 22
Pharma und Gesundheit: weitere Konsolidierung	Dec. 13
Farma en gezondheid: consolidatie gaat door	Dec. 12
Farmaceutica e salute: continua il consolidamento	Dec. 11
Farmacia y salud: La consolidación continúa	Dec. 11
Pharma & santé : poursuite de la consolidation	Dec. 11
Freeline Therapeutics Holdings plc Reports Earnings Results for the Nine Months Ended September 30, 2023	Dec. 01
Sector Update: Health Care Stocks Advance Late Afternoon	Nov. 22
Sector Update: Health Care Stocks Higher in Afternoon Trading	Nov. 22
Syncona agrees to buyout deal with Freeline Therapeutics	Nov. 22
Sector Update: Health Care Stocks Mixed Pre-Bell Wednesday	Nov. 22
Sector Update: Health Care	Nov. 22
Syncona to Take Over Freeline Therapeutics	Nov. 22
Freeline Therapeutics to be Acquired by Syncona for $28.3 Million	Nov. 22

No results for this search